title: Cyclosporine: what clinicians need to know.
abstract: Cyclosporine is known to be highly efficacious for the treatment of psoriasis as well as several other dermatologic conditions. Because of its profound anti-inflammatory properties and a side-effect profile that differs from other agents, such as methotrexate, the availability of cyclosporine confers certain advantages in meeting the challenges of treating recalcitrant psoriasis. In short-term use, cyclosporine can induce dramatic improvements in psoriasis, especially patients who present with intense inflammation. Because of nephrotoxicity and the possible development of hypertension, however, its utility in long-term usage, especially continuous usage beyond 1 year, is still to be defined. With contemporary attempts to use combination and rotational therapies to maximize therapeutic efficacy and minimize risk of long-term side effects, cyclosporine is definitely a welcome addition to our current armamentarium in the treatment of psoriasis.
authors.affiliation: Psoriasis Treatment Center and Phototherapy Unit, Psychodermatology Clinic, University of California San Franscisco Medical Center 94118, USA.
authors.forename: J
authors.initials: J
authors.lastname: Koo
authors.forename: J
authors.initials: J
authors.lastname: Lee
mesh_terms: D016572:Cyclosporine / Q000008:administration & dosage / Q000009:adverse effects / Q000493:pharmacokinetics / Q000494:pharmacology / Q000627:therapeutic use*; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000493:pharmacokinetics / Q000494:pharmacology / Q000627:therapeutic use*; D018579:Patient Selection; D011565:Psoriasis / Q000188:drug therapy*
chemical_list: D007166:Immunosuppressive Agents; D016572:Cyclosporine